Characteristics and outcomes in sero-positive late-onset rheumatoid arthritis patients who start a new disease modifying anti-rheumatic drug

被引：0
|
作者：
Ranganath, V. K. [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
ARTHRITIS RESEARCH & THERAPY | 2005年 / 7卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Propensity Score; Rheumatoid Factor; Generalize Match;
D O I：
10.1186/ar1687
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [41] Exploring the treatment burden of disease-modifying anti-rheumatic drug monitoring in people with rheumatoid arthritis
    Ryan, Sarah
    Bullock, Laurna
    Manning, Fay
    Chew-Graham, Carolyn A.
    Paskins, Zoe
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2023, 7 (02)
  • [42] COMPARATIVE EFFECTIVENESS OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG THERAPY IN US VETERANS WITH RHEUMATOID ARTHRITIS
    Cannon, G. W.
    He, T.
    Teng, C. -C.
    Leng, J.
    Lu, C. -C.
    Tang, D.
    Shah, N.
    Harrison, D. J.
    Sauer, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 446 - 447
  • [43] A PICTORIAL LEAFLET FOR COMBINED DISEASE-MODIFYING ANTI-RHEUMATIC DRUG THERAPY IN EARLY RHEUMATOID ARTHRITIS
    Balendra, Salini
    Ahmed, Azeem
    Price, Elizabeth
    Collins, David
    Williamson, Lyn
    RHEUMATOLOGY, 2014, 53 : 121 - 121
  • [44] Determinants and Impact of Early Initiation of Disease-Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis
    Keshavamurthy, Chandana
    Kuriakose, Kevin
    Chandra, Deepak
    Kaur, Aneet
    Spencer, Horace
    Khan, Nasim A.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1041 - S1041
  • [45] EFFECT OF GENDER ON DISEASE-MODIFYING ANTI-RHEUMATIC DRUG (DMARD) PRESCRIPTION IN RHEUMATOID ARTHRITIS (RA)
    Morrison, E.
    Hampson, R.
    Tierney, A.
    MacKenzie, L.
    Capell, H. A.
    RHEUMATOLOGY, 2004, 43 : 46 - 46
  • [46] New-onset atrial fibrillation in seropositive rheumatoid arthritis: association with disease-modifying anti-rheumatic drugs treatment
    Kim, Hyung Woo
    Han, Minkyung
    Jung, Inkyung
    Ahn, Sung Soo
    RHEUMATOLOGY, 2024, 63 (03) : 630 - 638
  • [47] ABATACEPT IS A SUITABLE BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH ANTI-SS-A ANTIBODIES-POSITIVE RHEUMATOID ARTHRITIS
    Horai, Y.
    Takatani, A.
    Nishino, A.
    Nakashima, Y.
    Suzuki, T.
    Fujikawa, K.
    Tsukada, T.
    Tsuboi, M.
    Matsuoka, N.
    Migita, K.
    Aramaki, T.
    Ueki, Y.
    Kawashiri, S. -Y.
    Iwamoto, N.
    Ichinose, K.
    Tamai, M.
    Nakamura, H.
    Origuchi, T.
    Kawakami, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 687 - 688
  • [48] Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis
    Chastek, Benjamin
    Becker, Laura K.
    Chen, Chieh-I
    Mahajan, Puneet
    Curtis, Jeffrey R.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (05) : 464 - 473
  • [49] Effect of glucocorticoids combined with disease modifying anti-rheumatic drugs on the improvement of symptoms in patients with rheumatoid arthritis
    Si, Lulu
    Jin, Yunyan
    Zhao, Dongni
    Yu, Lixia
    Cao, Huankun
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (04) : 976 - 980
  • [50] How much improvement in functioning is considered important by patients with active disease modifying anti-rheumatic drug refractory rheumatoid arthritis
    Singh, A
    Sato, R
    Wanke, L
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 108 - 108
12345